Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genomic Research Center, |
RCV000662154 | SCV000784501 | uncertain significance | Cerebellar ataxia, intellectual disability, and dysequilibrium syndrome 4 | 2018-03-05 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002530593 | SCV003551374 | uncertain significance | Inborn genetic diseases | 2022-06-09 | criteria provided, single submitter | clinical testing | The c.3439C>T (p.R1147W) alteration is located in exon 36 (coding exon 36) of the ATP8A2 gene. This alteration results from a C to T substitution at nucleotide position 3439, causing the arginine (R) at amino acid position 1147 to be replaced by a tryptophan (W). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Mayo Clinic Laboratories, |
RCV004792354 | SCV005408483 | uncertain significance | not provided | 2023-10-24 | criteria provided, single submitter | clinical testing | PM2_moderate |